Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
  1. 4 Grant or award Director acquired 57,000 shares (grant or award)
  2. 4 Grant or award Director acquired 57,000 shares (grant or award)
  3. 4 Open-market sale EVP, Chief Legal Officer sold 8,389 shares at an average $2.04 ($17,089)
  4. 4 Open-market sale EVP, Chief Technical Officer sold 19,040 shares at $2.04 ($38,784)
  5. 4 Open-market sale President and CEO sold 29,766 shares at $2.04 ($60,633)
  6. 4 Open-market sale SVP, CFO sold 7,918 shares at an average $2.04 ($16,131)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale President and CEO sold 15,679 shares at $3.63 ($56,868)
  9. 4 Open-market sale SVP, GC & Secretary sold 4,221 shares at $3.63 ($15,310)
  10. 4 Open-market sale Chief Financial Officer sold 6,871 shares at $3.63 ($24,921)
  11. 4 Open-market sale EVP, Head of R&D sold 5,074 shares at $3.63 ($18,403)
  12. 4 Grant or award President and CEO acquired 324,711 shares (grant or award)
  13. 4 Grant or award EVP, Chief Technical Officer acquired 139,700 shares (grant or award)
  14. 4 Grant or award EVP, Head of R&D acquired 141,328 shares (grant or award)
  15. 4 Grant or award SVP, GC & Secretary acquired 155,375 shares (grant or award)
  16. 4 Open-market sale Chief Financial Officer sold 2,485 shares at $5.46 ($13,568)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale EVP, Head of R&D sold 4,342 shares at an average $4.49 ($19,497)
  19. 4 Open-market sale President and CEO sold 15,591 shares at $4.49 ($70,004)
  20. 4 Open-market sale SVP, GC & Secretary sold 3,612 shares at $4.49 ($16,218)

Page 6 of 33 · 644 filings